An Observation Trial Without Surgical Treatment in Patients with Papillary Microcarcinoma of the Thyroid
By Yasuhiro Ito, T. Uruno, K. Nakano, Yuuki Takamura, A. Miya, Kaoru Kobayashi, T. Yokozawa, F. Matsuzuka, S. Kuma, K. Kuma and 1 more. Thyroid, 2003
800 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/f3a9a0bd9b68b943d28057269f19c63331abe873
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- H. Inoue
- M. Fukushima
- Yuuki Takamura
- C. Tomoda
Citations in the corpus
- An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients (2009, methodology): “We previously demonstrated that PMC patients having clinically apparent lateral node metastasis (N1b) were more likely to show recurrence [20, 21].”
- The Prognostic Significance of Nodal Metastases from Papillary Thyroid Carcinoma Can Be Stratified Based on the Size and Number of Metastatic Lymph Nodes, as Well as the Presence of Extranodal Extension (2012, neutral): “Even in patients followed with observation alone after identification of biopsy-proven PMC, the risk of developing clinically apparent LN metastases over a 5–10-year period was as low as 1% ( n = 340) (42,46) and 1.4% ( n = 230) (47).”
- Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. (2006, neutral): “The combination of factors improves the positive predictive value of US to some extent.(3,4) In particular, a predominantly solid nodule (G25% cystic) with microcalcifications has a 31.”